I read over the agenda and contents and there was no mention of AN's.
Pls reread the agenda. see below:
THORACIC & CENTRAL NERVOUS SYSTEM
10:50 – 11:00 Central Lung Tumors
Philippe A. Coucke, M.D., Ph.D., CHU Liege, Belgium
11:00 – 11:10 Acoustic Neuromas
Berndt Wowra, M.D., European CyberKnife Center Munich, GermanyAgain, this is not a direct issue with Dr Medbery not being forthright.... this is regarding who (RS or Accuray) doing the publications of works performed by the RS. This is solely a "business" issue and I can confirm, through my verbal discussions with Dr. Medbery and with someone at Accuray, that this does not impact personal relationship between them... again, a business decision that was made.
I have not lost faith in CK as an extremely viable option in the treatments of AN's as I am walking testament to it.... I am 5-1/2 yrs post treat and doing fine. Many AN'ers treated with CK for their AN's can also attest to the same. Again, this has nothing to do with CK as a choice for treatment on AN's.
Ok, had my left over halloween candy, in a sugar rush and spoke.
Phyl